Medigrowth is an innovative medicinal cannabis biotech company. We distribute our medicinal products (THC, CBD & dry flower) via multiple channels including our telehealth platform Haiku.Health.
We have delivered our Medigrowth products to thousands of Australian patients, nationwide, seeing YoY average revenue grow by 1200%. Our Deakin University collaboration provides us world-class resources and medical expertise.
Exciting clinical trial results with Medigrowth CBD highlight our commitment to evidence-based medicines. We're dedicated to improving lives for those with chronic health issues & with big plans ahead, we're ready to scale & make an even greater impact.